Literature DB >> 8771428

Transjugular intrahepatic portosystemic shunt for the management of hepatic hydrothorax in the absence of ascites.

R J Andrade1, A Martin-Palanca, J M Fraile, R Alcantara, C Carmona, M C Medina, V Muñoz, F Melgarejo.   

Abstract

Hepatic hydrothorax in the absence of clinical ascites (HHAA) is a somewhat rare complication in decompensated cirrhosis. Patients with HHAA have a congenital defect in the tendinous portion of the diaphragm allowing rapid leakage of ascites into pleural cavity because of the cyclical negative intrathoracic pressure. Although several therapeutic approaches, including peritoneovenous shunt and chemical or surgical pleurodesis, have been attempted in these patients the results are largely unsatisfactory. A poor-risk surgical cirrhotic woman who was also considered not suitable for liver transplantation underwent transjugular intrahepatic portosystemic shunt (TIPS) for palliation of HHAA. After TIPS procedure hydrothorax completely resolved. TIPS can offer an attractive alternative to standard therapy in cirrhotic patients with HHAA.

Entities:  

Mesh:

Year:  1996        PMID: 8771428     DOI: 10.1097/00004836-199606000-00013

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  7 in total

1.  A successful surgical repair of the hepatic hydrothorax using pneumoperitoneum: report of a case.

Authors:  T Yaguchi; A Harada; T Sakakibara; Y Komatsu; S Yoshida; K Yokoi; H Murakami; Y Fukuhara
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

Review 2.  Current status of transjugular intrahepatic portosystemic shunts.

Authors:  N H Patel; N Chalasani; R M Jindal
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

3.  Outcomes of patients with chest tube insertion for hepatic hydrothorax.

Authors:  Eric S Orman; Anna S F Lok
Journal:  Hepatol Int       Date:  2009-08-11       Impact factor: 6.047

Review 4.  The use and misuse of transjugular intrahepatic portasystemic shunts.

Authors:  A J Sanyal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

5.  Transjugular intrahepatic portosystemic stent shunt for medically refractory hepatic hydrothorax: A systematic review and cumulative meta-analysis.

Authors:  Ivo C Ditah; Badr F Al Bawardy; Behnam Saberi; Chobufo Ditah; Patrick S Kamath
Journal:  World J Hepatol       Date:  2015-07-08

Review 6.  Outcomes of transjugular intrahepatic portosystemic shunts for ascites.

Authors:  Zachary L Bercu; Aaron M Fischman
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

7.  Chemical pleurodesis for the management of refractory hepatic hydrothorax in patients with decompensated liver cirrhosis.

Authors:  Woo Jin Lee; Hong Joo Kim; Jung Ho Park; Dong Il Park; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim
Journal:  Korean J Hepatol       Date:  2011-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.